Hope Medicine

Developer of monoclonal antibodies for the treatment of multiple diseases

placeShanghai, Shanghai, China calendar_todayFounded 2018 language hopemedinc.com

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 100 times.

YearFilings
20211
20221
20251

Investor mix

9 investors on record; lead investors include Qiming Venture Partners, Ennovation Ventures, Sinovation Ventures.

Investor typeCountShare
Venture capital556%
Private equity111%
Other / undisclosed333%
Coming soon